|
Garvinci International Inc. is a subsidiary corporation of Garvinci Inc., and possesses in exclusive ownership an establishment license for Ostenil® on the Canadian market.
Garvinci possesses an establishment license for medical instruments issued by Health Canada’s Health Products and Food Branch Inspectorate.
Garvinci is a pharmaceutical corporation that develops and adapts European products for the Canadian market.
Garvinci acquires licenses for innovative medical and pharmaceutical products for marketing and distribution, specifically in fields such as orthopedics, rheumatology and women’s health.
We value our clients’ opinions and welcome comments about our company and its products.
|
